Refine Search

Wall Street Focus: Combating diabetes

The world's largest drugmakers recently received some good news. A new class of diabetes drugs was found not to increase the risk of heart attack and stroke - deadly side effects which have plagued some older diabetes treatments.
Medicine Today: Treatment time improving for heart attacks

A new study in the New England Journal of Medicine suggests that we may be getting better at treating heart attacks.
Physical therapy or surgery for knee pain

Some doctors will recommend surgery to fix the meniscal tear while others will recommend a more conservative approach with physical therapy.
Military families shoulder weight of deployment

When Sgt. 1st Class Jamie Me­nard deploys from Fort Gor­don, the entire Me­nard family, which has endured four deployments in 10 years, becomes afraid for the worst.
Delayed care higher in South, study finds

All too often for people like Sheryl Redman, particularly in the South, cost is a barrier to getting care particularly in states with restrictive Medicaid eligibility, a study published Thursday finds.
Soda industry launches 'calorie count' vending machines

As criticism of sugary sodas intensifies, Coke, Pepsi and Dr Pepper are rolling out new vending machines that will put calorie counts right at your fingertips.
MCG to test skin cancer medication

The worst part of being treated for advanced skin cancer is the flu-like aftershock from chemotherapy that lays out Mary Cayer in front of her four young children.
Health | Metro
Spanish flu link could explain H1N1's spread

It seemed to come out of nowhere in April, when it was diagnosed in two unrelated children in California.
Metro | Swine flu
'Tort reform' a clever distraction

This effort diverts us from the real issue at hand -- affordable, attainable and safe health care.
Opinion columns
Study takes second look at cancer drug Iressa

ATLANTA --- Four years after the government severely restricted its use, the lung cancer drug Iressa may be poised to make a comeback: A study concludes it can slow the deadly disease better than standard chemotherapy in certain patients.